Center for Stem Cell & Organoid Medicine (CuSTOM)
Translation and Commercialization

CuSTOM Accelerator


Catalyzing the Organoid Medicine Revolution 

At the CuSTOM Accelerator, we leverage our key discoveries in stem cell biology and organ development to create and apply innovative organoid-based platforms to unmet medical needs. These include organoid-based platforms enabling discovery and development of safer and more efficient drugs, precision medicine applications and organoid-based therapies to advance human health and medical practices.


Creating a healthier society by accelerating discovery and bench-to-bedside translation of organoid technology through academic-industrial partnerships, licensing agreements, and the creation of startups.


At CuSTOM Accelerator we are actively seeking strategic relationships with biopharmaceutical companies, leading academic and medical institutions which are interested in working together to advance a versatile organoid medicine centered on induced pluripotent stem cells.

In CuSTOM Accelerator scientists and engineers work alongside experts in industrial product and business development, intellectual property, and entrepreneurship to develop new technologies, and to de-risk them, ensuring the fastest and most successful path to commercialization.

Contact Us

For more information about the CuSTOM Accelerator, collaboration options or career opportunities, please contact Magdalena Kasendra at


Organoid Technology provides an unprecedented opportunity to model human disease, bridge preclinical and clinical drug development, revolutionize personalized medicine and improve patient care.


Through our 3D Innovation Process, we transform breakthrough ideas and discoveries of CuSTOM Academic Research into mature, de-risked and validated technologies to be delivered to a wide range of patients worldwide.

Focus Areas

We are passionate about delivering on the promise of organoid technology by developing groundbreaking and innovative solutions that are translated into commercial products and therapies for millions of patients worldwide.